These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 32807047)

  • 61. Systems pharmacological study illustrates the immune regulation, anti-infection, anti-inflammation, and multi-organ protection mechanism of Qing-Fei-Pai-Du decoction in the treatment of COVID-19.
    Zhao J; Tian S; Lu D; Yang J; Zeng H; Zhang F; Tu D; Ge G; Zheng Y; Shi T; Xu X; Zhao S; Yang Y; Zhang W
    Phytomedicine; 2021 May; 85():153315. PubMed ID: 32978039
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Herbal approach for the management of C0VID-19: an overview.
    Fatima S; Haider N; Alam MA; Gani MA; Ahmad R;
    Drug Metab Pers Ther; 2020 Nov; ():. PubMed ID: 33128525
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Chemical composition and pharmacological mechanism of shenfu decoction in the treatment of novel coronavirus
    Li X; Lin H; Wang Q; Cui L; Luo H; Luo L
    Drug Dev Ind Pharm; 2020 Dec; 46(12):1947-1959. PubMed ID: 33054436
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Glycyrrhizin: An old weapon against a novel coronavirus.
    Chrzanowski J; Chrzanowska A; Graboń W
    Phytother Res; 2021 Feb; 35(2):629-636. PubMed ID: 32902005
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Network pharmacology analysis of the therapeutic mechanisms of the traditional Chinese herbal formula Lian Hua Qing Wen in Corona virus disease 2019 (COVID-19), gives fundamental support to the clinical use of LHQW.
    Zheng S; Baak JP; Li S; Xiao W; Ren H; Yang H; Gan Y; Wen C
    Phytomedicine; 2020 Dec; 79():153336. PubMed ID: 32949888
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Glycyrrhizic acid exerts inhibitory activity against the spike protein of SARS-CoV-2.
    Yu S; Zhu Y; Xu J; Yao G; Zhang P; Wang M; Zhao Y; Lin G; Chen H; Chen L; Zhang J
    Phytomedicine; 2021 May; 85():153364. PubMed ID: 33041173
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Traditional Chinese Medicine as Potential Therapy for COVID-19.
    Li S; Liu C; Guo F; Taleb SJ; Tong M; Shang D
    Am J Chin Med; 2020; 48(6):1263-1277. PubMed ID: 32907358
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Quercetin Phytosome® as a potential candidate for managing COVID-19.
    DI Pierro F; Khan A; Bertuccioli A; Maffioli P; Derosa G; Khan S; Khan BA; Nigar R; Ujjan I; Devrajani BR
    Minerva Gastroenterol (Torino); 2021 Jun; 67(2):190-195. PubMed ID: 33016666
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The inhibitory effect of some natural bioactive compounds against SARS-CoV-2 main protease: insights from molecular docking analysis and molecular dynamic simulation.
    Abdelrheem DA; Ahmed SA; Abd El-Mageed HR; Mohamed HS; Rahman AA; Elsayed KNM; Ahmed SA
    J Environ Sci Health A Tox Hazard Subst Environ Eng; 2020; 55(11):1373-1386. PubMed ID: 32998618
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Bioactive natural compounds against human coronaviruses: a review and perspective.
    Xian Y; Zhang J; Bian Z; Zhou H; Zhang Z; Lin Z; Xu H
    Acta Pharm Sin B; 2020 Jul; 10(7):1163-1174. PubMed ID: 32834947
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Immunity against COVID-19: Potential role of
    Gautam S; Gautam A; Chhetri S; Bhattarai U
    J Ayurveda Integr Med; 2022; 13(1):100350. PubMed ID: 32837101
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Repurposing of the approved small molecule drugs in order to inhibit SARS-CoV-2 S protein and human ACE2 interaction through virtual screening approaches.
    Kalhor H; Sadeghi S; Abolhasani H; Kalhor R; Rahimi H
    J Biomol Struct Dyn; 2022 Feb; 40(3):1299-1315. PubMed ID: 32969333
    [TBL] [Abstract][Full Text] [Related]  

  • 73. In Silico Identification of Potential Natural Product Inhibitors of Human Proteases Key to SARS-CoV-2 Infection.
    Vivek-Ananth RP; Rana A; Rajan N; Biswal HS; Samal A
    Molecules; 2020 Aug; 25(17):. PubMed ID: 32842606
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Antiviral Essential Oils Incorporated in Nanocarriers: Strategy for Prevention from COVID-19 and Future Infectious Pandemics.
    Kaur M; Devi G; Nagpal M; Singh M; Dhingra GA; Aggarwal G
    Pharm Nanotechnol; 2020; 8(6):437-451. PubMed ID: 33069206
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Effects of Ginger on clinical manifestations and paraclinical features of patients with Severe Acute Respiratory Syndrome due to COVID-19: A structured summary of a study protocol for a randomized controlled trial.
    Safa O; Hassaniazad M; Farashahinejad M; Davoodian P; Dadvand H; Hassanipour S; Fathalipour M
    Trials; 2020 Oct; 21(1):841. PubMed ID: 33036662
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The upshot of Polyphenolic compounds on immunity amid COVID-19 pandemic and other emerging communicable diseases: An appraisal.
    Khalil A; Tazeddinova D
    Nat Prod Bioprospect; 2020 Dec; 10(6):411-429. PubMed ID: 33057955
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Systems Pharmacology and Verification of ShenFuHuang Formula in Zebrafish Model Reveal Multi-Scale Treatment Strategy for Septic Syndrome in COVID-19.
    Liu T; Guo Y; Zhao J; He S; Bai Y; Wang N; Lin Y; Liu Q; Xu X
    Front Pharmacol; 2020; 11():584057. PubMed ID: 33041827
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Discovery of Some Antiviral Natural Products to Fight Against Novel Coronavirus (SARS-CoV-2) Using an
    Shah A; Patel V; Parmar B
    Comb Chem High Throughput Screen; 2021; 24(8):1271-1280. PubMed ID: 32881661
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Drug repurposing for COVID-19: could vitamin C combined with glycyrrhizic acid be at play by the findings of Li et al.'s database-based network pharmacology analysis?
    Huang YX; Wang WX; Tang YP; Yue SJ
    Brief Bioinform; 2021 Mar; 22(2):1508-1510. PubMed ID: 33253353
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Chemical composition and pharmacological mechanism of ephedra-glycyrrhiza drug pair against coronavirus disease 2019 (COVID-19).
    Li X; Qiu Q; Li M; Lin H; Cao S; Wang Q; Chen Z; Jiang W; Zhang W; Huang Y; Luo H; Luo L
    Aging (Albany NY); 2021 Feb; 13(4):4811-4830. PubMed ID: 33581688
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.